Cargando…

Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are some of the biggest public health challenges due to their spread and increasing incidence around the world. NAFLD is characterized by intrahepatic lipid deposition, accompanied by dyslipidemia, hypertension, and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Pasqua, Laura Giuseppina, Cagna, Marta, Berardo, Clarissa, Vairetti, Mariapia, Ferrigno, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774221/ https://www.ncbi.nlm.nih.gov/pubmed/35052872 http://dx.doi.org/10.3390/biomedicines10010194

Ejemplares similares

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
por: Berardo, Clarissa, et al.
Publicado: (2020)

Changes in Glutathione Content in Liver Diseases: An Update
por: Vairetti, Mariapia, et al.
Publicado: (2021)

Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress Versus Metalloproteinases
por: Palladini, Giuseppina, et al.
Publicado: (2019)

Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2021)

The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis
por: Ferrigno, Andrea, et al.
Publicado: (2020)

Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease
por: Palladini, Giuseppina, et al.
Publicado: (2020)

Metabotropic Glutamate Receptor Blockade Reduces Preservation Damage in Livers from Donors after Cardiac Death
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2021)

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress
por: Palladini, Giuseppina, et al.
Publicado: (2019)

Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats
por: Palladini, Giuseppina, et al.
Publicado: (2022)

MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis
por: Palladini, Giuseppina, et al.
Publicado: (2022)

MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice
por: Ferrigno, Andrea, et al.
Publicado: (2023)

Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
por: Vairetti, Mariapia, et al.
Publicado: (2022)

Selective Blockade of the Metabotropic Glutamate Receptor mGluR5 Protects Mouse Livers in In Vitro and Ex Vivo Models of Ischemia Reperfusion Injury
por: Ferrigno, Andrea, et al.
Publicado: (2018)

Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV
por: Berardo, Clarissa, et al.
Publicado: (2020)

Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2022)

Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium
por: Ferrigno, Andrea, et al.
Publicado: (2017)

Liver Graft Susceptibility during Static Cold Storage and Dynamic Machine Perfusion: DCD versus Fatty Livers
por: Ferrigno, Andrea, et al.
Publicado: (2017)

Spectrofluorometric Analysis of Autofluorescing Components of Crude Serum from a Rat Liver Model of Ischemia and Reperfusion
por: Croce, Anna C., et al.
Publicado: (2020)

Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma
por: Berardo, Clarissa, et al.
Publicado: (2019)

Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract
por: Ferrigno, Andrea, et al.
Publicado: (2017)

The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury
por: Ferrigno, Andrea, et al.
Publicado: (2018)

Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion
por: Croce, Anna C., et al.
Publicado: (2023)

SerpinB3 administration protects liver against ischemia-reperfusion injury
por: Turato, Cristian, et al.
Publicado: (2022)

Changes in ADMA/DDAH Pathway after Hepatic Ischemia/Reperfusion Injury in Rats: The Role of Bile
por: Ferrigno, Andrea, et al.
Publicado: (2014)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury
por: Ferrigno, Andrea, et al.
Publicado: (2020)

Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis
por: Atanasovska, Biljana, et al.
Publicado: (2021)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Iravani, Farzaneh, et al.
Publicado: (2018)

Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Ahsan, Farah, et al.
Publicado: (2020)

Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver
por: Li, Chao, et al.
Publicado: (2020)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
por: Ghandian, Sina, et al.
Publicado: (2022)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways
por: Ferrigno, Andrea, et al.
Publicado: (2020)

Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
por: Daher, Saleh, et al.
Publicado: (2018)

Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kim, Jeong Woo, et al.
Publicado: (2020)

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
por: Hattori, Sachiko, et al.
Publicado: (2021)

Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis
por: Ma, Mengyao, et al.
Publicado: (2021)

Serum and Hepatic Autofluorescence as a Real-Time Diagnostic Tool for Early Cholestasis Assessment
por: Croce, Anna C., et al.
Publicado: (2018)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m8tauo3mtav6jinl5l88rce392